Literature DB >> 16081967

Evaluation of beta-lactamase inhibitors in disk tests for detection of plasmid-mediated AmpC beta-lactamases in well-characterized clinical strains of Klebsiella spp.

Jennifer A Black1, Kenneth S Thomson, John D Buynak, Johann D D Pitout.   

Abstract

The diagnostic utility of the AmpC beta-lactamase inhibitors LN-2-128, 48-1220, and Syn 2190 in combination with cefotetan (CTT) or cefoxitin in a disk test for the detection of clinical isolates of Klebsiella spp. producing plasmid-mediated AmpC beta-lactamases (pAmpCs) was evaluated. The combination of Syn 2190 and CTT had a sensitivity of 91%, a specificity of 100%, and a reproducibility of 100% and showed the best potential of using an inhibitor for detection of Klebsiella spp. producing pAmpCs.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16081967      PMCID： PMC1233919          DOI： 10.1128/JCM.43.8.4168-4171.2005

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  20 in total

1.  Detection of plasmid-mediated AmpC beta-lactamase genes in clinical isolates by using multiplex PCR.

Authors:  F Javier Pérez-Pérez; Nancy D Hanson
Journal:  J Clin Microbiol       Date:  2002-06       Impact factor: 5.948

2.  Relationship between outer membrane alterations and susceptibility to antimicrobial agents in isogenic strains of Klebsiella pneumoniae.

Authors:  S Hernández-Allés; M d Conejo; A Pascual; J M Tomás; V J Benedí; L Martínez-Martínez
Journal:  J Antimicrob Chemother       Date:  2000-08       Impact factor: 5.790

3.  Use of beta-lactamase inhibitors in disk tests to detect plasmid-mediated AmpC beta-lactamases.

Authors:  Jennifer A Black; Kenneth S Thomson; Johann D D Pitout
Journal:  J Clin Microbiol       Date:  2004-05       Impact factor: 5.948

4.  Outbreak of Klebsiella pneumoniae producing transferable AmpC-type beta-lactamase (ACC-1) originating from Hafnia alvei.

Authors:  D Nadjar; M Rouveau; C Verdet; L Donay; J Herrmann; P H Lagrange; A Philippon; G Arlet
Journal:  FEMS Microbiol Lett       Date:  2000-06-01       Impact factor: 2.742

5.  Cephalosporin-derived inhibitors of beta-lactamase. Part 4: The C3 substituent.

Authors:  John D Buynak; Lakshminarayana Vogeti; Venkata Ramana Doppalapudi; George Martin Solomon; Hansong Chen
Journal:  Bioorg Med Chem Lett       Date:  2002-06-17       Impact factor: 2.823

6.  Epidemiology and clinical features of bloodstream infections caused by AmpC-type-beta-lactamase-producing Klebsiella pneumoniae.

Authors:  Hyunjoo Pai; Cheol-In Kang; Jeong-Hum Byeon; Ki-Deok Lee; Wan Beom Park; Hong-Bin Kim; Eui-Chong Kim; Myoung-Don Oh; Kang-Won Choe
Journal:  Antimicrob Agents Chemother       Date:  2004-10       Impact factor: 5.191

7.  Occurrence of extended-spectrum and AmpC beta-lactamases in bloodstream isolates of Klebsiella pneumoniae: isolates harbor plasmid-mediated FOX-5 and ACT-1 AmpC beta-lactamases.

Authors:  Philip E Coudron; Nancy D Hanson; Michael W Climo
Journal:  J Clin Microbiol       Date:  2003-02       Impact factor: 5.948

8.  Further modification of the Hodge test to screen AmpC beta-lactamase (CMY-1)-producing strains of Escherichia coli and Klebsiella pneumoniae.

Authors:  Dongeun Yong; Rojin Park; Jong Hwa Yum; Kyungwon Lee; Eung Chil Choi; Yunsop Chong
Journal:  J Microbiol Methods       Date:  2002-11       Impact factor: 2.363

9.  New method for laboratory detection of AmpC beta-lactamases in Escherichia coli and Klebsiella pneumoniae.

Authors:  K Nasim; S Elsayed; J D D Pitout; J Conly; D L Church; D B Gregson
Journal:  J Clin Microbiol       Date:  2004-10       Impact factor: 5.948

10.  Occurrence and detection of AmpC beta-lactamases among Gram-negative clinical isolates using a modified three-dimensional test at Guru Tegh Bahadur Hospital, Delhi, India.

Authors:  Vikas Manchanda; Narendra P Singh
Journal:  J Antimicrob Chemother       Date:  2003-02       Impact factor: 5.790
View more
  10 in total

Review 1.  Current concepts in laboratory testing to guide antimicrobial therapy.

Authors:  Stephen G Jenkins; Audrey N Schuetz
Journal:  Mayo Clin Proc       Date:  2012-03       Impact factor: 7.616

2.  First detection of the Ambler class C 1 AmpC beta-lactamase in Citrobacter freundii by a new, simple double-disk synergy test.

Authors:  Etienne Ruppé; Philippe Bidet; Charlotte Verdet; Guillaume Arlet; Edouard Bingen
Journal:  J Clin Microbiol       Date:  2006-09-13       Impact factor: 5.948

3.  Identification of extended-spectrum, AmpC, and carbapenem- hydrolyzing beta-lactamases in Escherichia coli and Klebsiella pneumoniae by disk tests.

Authors:  George A Jacoby; Kelley E Walsh; Victoria J Walker
Journal:  J Clin Microbiol       Date:  2006-06       Impact factor: 5.948

Review 4.  A Primer on AmpC β-Lactamases: Necessary Knowledge for an Increasingly Multidrug-resistant World.

Authors:  Pranita D Tamma; Yohei Doi; Robert A Bonomo; J Kristie Johnson; Patricia J Simner
Journal:  Clin Infect Dis       Date:  2019-09-27       Impact factor: 9.079

Review 5.  AmpC beta-lactamases.

Authors:  George A Jacoby
Journal:  Clin Microbiol Rev       Date:  2009-01       Impact factor: 26.132

Review 6.  Three decades of beta-lactamase inhibitors.

Authors:  Sarah M Drawz; Robert A Bonomo
Journal:  Clin Microbiol Rev       Date:  2010-01       Impact factor: 26.132

7.  Molecular description of plasmid-mediated AmpC β-lactamases among nosocomial isolates of Escherichia coli & Klebsiella pneumoniae from six different hospitals in India.

Authors:  Parveen R Mohamudha; B N Harish; S C Parija
Journal:  Indian J Med Res       Date:  2012       Impact factor: 2.375

8.  Molecular Characterization of Extended Spectrum β-lactamase and Carbapenemase Producing Klebsiella pneumoniae from a Tertiary Care Hospital.

Authors:  Beena Hosdurg Bhaskar; Shalini Shenoy Mulki; Sangeetha Joshi; Ranjeeta Adhikary; Bhavana Malavalli Venkatesh
Journal:  Indian J Crit Care Med       Date:  2019-02

9.  Population-based laboratory surveillance for AmpC beta-lactamase-producing Escherichia coli, Calgary.

Authors:  Johann D D Pitout; Daniel B Gregson; Deirdre L Church; Kevin B Laupland
Journal:  Emerg Infect Dis       Date:  2007-03       Impact factor: 6.883

10.  Systematic Review of Plasmid AmpC Type Resistances in Escherichia coli and Klebsiella pneumoniae and Preliminary Proposal of a Simplified Screening Method for ampC.

Authors:  Enrique Rodríguez-Guerrero; Juan Carlos Callejas-Rodelas; José María Navarro-Marí; José Gutiérrez-Fernández
Journal:  Microorganisms       Date:  2022-03-14
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.